223 related articles for article (PubMed ID: 21685385)
1. Structural basis of M3 muscarinic receptor dimer/oligomer formation.
McMillin SM; Heusel M; Liu T; Costanzi S; Wess J
J Biol Chem; 2011 Aug; 286(32):28584-98. PubMed ID: 21685385
[TBL] [Abstract][Full Text] [Related]
2. Novel structural and functional insights into M3 muscarinic receptor dimer/oligomer formation.
Hu J; Hu K; Liu T; Stern MK; Mistry R; Challiss RA; Costanzi S; Wess J
J Biol Chem; 2013 Nov; 288(48):34777-90. PubMed ID: 24133207
[TBL] [Abstract][Full Text] [Related]
3. Structural aspects of M₃ muscarinic acetylcholine receptor dimer formation and activation.
Hu J; Thor D; Zhou Y; Liu T; Wang Y; McMillin SM; Mistry R; Challiss RA; Costanzi S; Wess J
FASEB J; 2012 Feb; 26(2):604-16. PubMed ID: 22031716
[TBL] [Abstract][Full Text] [Related]
4. Multiple residues in the second extracellular loop are critical for M3 muscarinic acetylcholine receptor activation.
Scarselli M; Li B; Kim SK; Wess J
J Biol Chem; 2007 Mar; 282(10):7385-96. PubMed ID: 17213190
[TBL] [Abstract][Full Text] [Related]
5. Ligand-specific changes in M3 muscarinic acetylcholine receptor structure detected by a disulfide scanning strategy.
Li JH; Hamdan FF; Kim SK; Jacobson KA; Zhang X; Han SJ; Wess J
Biochemistry; 2008 Mar; 47(9):2776-88. PubMed ID: 18247581
[TBL] [Abstract][Full Text] [Related]
6. Use of an in situ disulfide cross-linking strategy to study the dynamic properties of the cytoplasmic end of transmembrane domain VI of the M3 muscarinic acetylcholine receptor.
Ward SD; Hamdan FF; Bloodworth LM; Siddiqui NA; Li JH; Wess J
Biochemistry; 2006 Jan; 45(3):676-85. PubMed ID: 16411743
[TBL] [Abstract][Full Text] [Related]
7. Random mutagenesis of the M3 muscarinic acetylcholine receptor expressed in yeast: identification of second-site mutations that restore function to a coupling-deficient mutant M3 receptor.
Li B; Nowak NM; Kim SK; Jacobson KA; Bagheri A; Schmidt C; Wess J
J Biol Chem; 2005 Feb; 280(7):5664-75. PubMed ID: 15572356
[TBL] [Abstract][Full Text] [Related]
8. Use of an in situ disulfide cross-linking strategy to map proximities between amino acid residues in transmembrane domains I and VII of the M3 muscarinic acetylcholine receptor.
Hamdan FF; Ward SD; Siddiqui NA; Bloodworth LM; Wess J
Biochemistry; 2002 Jun; 41(24):7647-58. PubMed ID: 12056896
[TBL] [Abstract][Full Text] [Related]
9. Identification and molecular characterization of m3 muscarinic receptor dimers.
Zeng FY; Wess J
J Biol Chem; 1999 Jul; 274(27):19487-97. PubMed ID: 10383466
[TBL] [Abstract][Full Text] [Related]
10. Conformational changes that occur during M3 muscarinic acetylcholine receptor activation probed by the use of an in situ disulfide cross-linking strategy.
Ward SD; Hamdan FF; Bloodworth LM; Wess J
J Biol Chem; 2002 Jan; 277(3):2247-57. PubMed ID: 11698401
[TBL] [Abstract][Full Text] [Related]
11. Rapid identification of functionally critical amino acids in a G protein-coupled receptor.
Li B; Scarselli M; Knudsen CD; Kim SK; Jacobson KA; McMillin SM; Wess J
Nat Methods; 2007 Feb; 4(2):169-74. PubMed ID: 17206152
[TBL] [Abstract][Full Text] [Related]
12. The molecular basis of oligomeric organization of the human M3 muscarinic acetylcholine receptor.
Liste MJ; Caltabiano G; Ward RJ; Alvarez-Curto E; Marsango S; Milligan G
Mol Pharmacol; 2015 Jun; 87(6):936-53. PubMed ID: 25769304
[TBL] [Abstract][Full Text] [Related]
13. Random mutagenesis of the M3 muscarinic acetylcholine receptor expressed in yeast. Identification of point mutations that "silence" a constitutively active mutant M3 receptor and greatly impair receptor/G protein coupling.
Schmidt C; Li B; Bloodworth L; Erlenbach I; Zeng FY; Wess J
J Biol Chem; 2003 Aug; 278(32):30248-60. PubMed ID: 12750375
[TBL] [Abstract][Full Text] [Related]
14. Pronounced conformational changes following agonist activation of the M(3) muscarinic acetylcholine receptor.
Han SJ; Hamdan FF; Kim SK; Jacobson KA; Brichta L; Bloodworth LM; Li JH; Wess J
J Biol Chem; 2005 Jul; 280(26):24870-9. PubMed ID: 15870064
[TBL] [Abstract][Full Text] [Related]
15. Regulation of M₃ muscarinic receptor expression and function by transmembrane protein 147.
Rosemond E; Rossi M; McMillin SM; Scarselli M; Donaldson JG; Wess J
Mol Pharmacol; 2011 Feb; 79(2):251-61. PubMed ID: 21056967
[TBL] [Abstract][Full Text] [Related]
16. Functional importance of a structurally distinct homodimeric complex of the family B G protein-coupled secretin receptor.
Gao F; Harikumar KG; Dong M; Lam PC; Sexton PM; Christopoulos A; Bordner A; Abagyan R; Miller LJ
Mol Pharmacol; 2009 Aug; 76(2):264-74. PubMed ID: 19429716
[TBL] [Abstract][Full Text] [Related]
17. Conserved extracellular cysteine pair in the M3 muscarinic acetylcholine receptor is essential for proper receptor cell surface localization but not for G protein coupling.
Zeng FY; Soldner A; Schöneberg T; Wess J
J Neurochem; 1999 Jun; 72(6):2404-14. PubMed ID: 10349850
[TBL] [Abstract][Full Text] [Related]
18. Spinophilin as a novel regulator of M3 muscarinic receptor-mediated insulin release in vitro and in vivo.
Ruiz de Azua I; Nakajima K; Rossi M; Cui Y; Jou W; Gavrilova O; Wess J
FASEB J; 2012 Oct; 26(10):4275-86. PubMed ID: 22730439
[TBL] [Abstract][Full Text] [Related]
19. The muscarinic M3 acetylcholine receptor exists as two differently sized complexes at the plasma membrane.
Patowary S; Alvarez-Curto E; Xu TR; Holz JD; Oliver JA; Milligan G; Raicu V
Biochem J; 2013 Jun; 452(2):303-12. PubMed ID: 23521066
[TBL] [Abstract][Full Text] [Related]
20. Identification of an agonist-induced conformational change occurring adjacent to the ligand-binding pocket of the M(3) muscarinic acetylcholine receptor.
Han SJ; Hamdan FF; Kim SK; Jacobson KA; Bloodworth LM; Li B; Wess J
J Biol Chem; 2005 Oct; 280(41):34849-58. PubMed ID: 16093246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
